Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole for anhedonic depression
2022-001563-26Phase 3Active
- Sponsor
- Region Skåne
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) comparing Pramipexole with Placebo (2 arms). Started Aug 2022; status: active.
02
Drugs
pramipexole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2022-001563-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001563-26.